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Abstract
Scalable methods, PRINT® particle fabrication and spray-assisted Layer-by-Layer deposition, are
combined to generate uniform and functional nanotechnologies with precise control over
composition, size, shape, and surface functionality. A modular and tunable approach towards
design of built-to-order nanoparticle systems, spray coating on PRINT® particles is demonstrated
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to achieve technologies capable of targeted interactions with cancer cells for applications in drug
delivery.
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Core/Shell Nanoparticles; Thin Films; Nanoimprinting
A significant limitation in the design of new nanotechnologies for drug delivery is the
balance between efficacy, safety, and scalability – the three major hurdles to streamlined
approval towards the clinic and, ultimately, adaptation in the pharmaceutical industry.
Oftentimes, these aspects of nanomedicine are competing, and impose challenging design
requirements on systems synthesized in the laboratory. Resource-intensive syntheses or
purification procedures, limited material yields, and the difficulty of precisely controlling
particle size, morphology, and composition for increasingly complex systems are some of
the major challenges that continue to prevent the translation of promising technologies away
from the bench-top. For this reason, it is highly desirable to conceive of simple, scalable,
and highly controlled methodologies for the manufacture of multi-functional nanoparticles
that possess the necessary physicochemical characteristics to be clinically relevant.[1]
The surface chemistry of nanoparticles plays a major role in determining their biological
properties. However, many of the current methodologies used to modify the surfaces of
nanoparticles are inefficient and labor intensive. Layer-by-layer (LbL) polyelectrolyte
deposition is an attractive process for incorporating functionality onto the surfaces of
nanocarriers to provide improved stability, enhanced cellular uptake, and targeting
capabilities.[2-4] Because small molecule drugs and biologics such as nucleic acids can be
included in the nanolayers, it also affords the ability to incorporate additional therapeutics
that act as synergistic drug combinations[5] on a single nanoscopic platform and in a fashion
such that the release of each can be programmed.[6] Although the use of LbL to modify the
surfaces of bulk solids has been known for years, only recently has this technology been
successfully applied to nanoparticles for medical applications[7] and only in the past couple
of years has it been demonstrated that such systems can exhibit extended biodistribution for
systemic in vivo delivery[2] and tumor-responsive properties[3] in mouse models. A great
deal of promise exists for LbL nanoparticle technologies; however, in contrast to LbL
deposition onto bulk surfaces (which is highly efficient and can be performed rapidly using
automated dip or spray protocols), LbL functionalization of nanoparticles is comparatively
slow and inefficient, typically requiring several centrifugal purification steps between the
deposition of subsequent polyelectrolyte layers. Given that for drug delivery it is often
desirable to test different surface functionalities and drug combinations, it would be of great
interest to develop an LbL platform for NP functionalization that takes advantage of the high
throughput and efficiency of more recently developed rapid LbL techniques.
Particle fabrication using the Particle Replication in Non-wetting Templates (PRINT®)
process is a well-established, scalable approach[8] for rapidly manufacturing particles with
exquisite control over particle geometry (size, shape) and composition (cargo, carrier
system), important parameters for optimizing cellular engagement and in vivo
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pharmacokinetics.[8-10] Through a roll-to-roll process, an elastomeric mold is implemented
in a high-throughput fashion to generate monodisperse particles with well-defined
geometries. By varying the properties of the elastomeric mold, particles can be produced
with a dynamic range of shapes and sizes, varying from 10 nm - 200 μm. Further, particles
prior to recovery are presented in an ideal, ordered spatial arrangement that presents an
attractive opportunity for high-throughput surface functionalization methodologies, such as
LbL. The ability to fabricate precisely controlled nanotechnologies on a large scale is highly
attractive towards expedient approval through regulatory pathways.[11]
Purification and surface functionalization of PRINT® particles, however, endures all of the
challenges faced by other synthesis techniques. Following particle fabrication, purification
from the solubilized transfer adhesive film is limited by traditional means (e.g.
ultracentrifugation, tangential-flow filtration). Post-purification modification is generally
required to achieve effective surface modification using the more traditional techniques
available to the biomaterials community at-large for yielding functional particle systems.
Oftentimes, these bioconjugation or functionalization chemistries are difficult and expensive
to scale and result in significant material loss. The ability to control surface characteristics is
essential to improve performance of nanotechnologies regarding enhanced specific
molecular interactions with target cells, as well as avoid non-specific clearance in vivo via
protein-resistive properties.[12] Surfaces largely mediate interactions at the interface of
biology; therefore, the desire to incorporate a technology with the ability to include a library
of materials on the surface of PRINT® particles in an analogous high throughput, scalable
fashion is highly desirable, and one that holds much promise for the future of multi-
functional nanotechnology manufacture.
Towards the development of a complementary, scalable approach for the surface
functionalization of roll-to-roll assembled functional nanoparticles, we demonstrate that
spray-assisted Layer-by-Layer (Spray-LbL) deposition may be used to generate highly-
controlled functional coatings in a rapid, reproducible, and facile manner on a generalizable
platform of particle systems, as illustrated in Scheme 1. Spray-LbL has been shown[13] to
conformally coat materials on the nanoscale in a controllable fashion, with extremely thin
layers deposited on the surface of various charged substrate materials, including 3D
structures such as electrospun mats. The combination of PRINT® and LbL technologies
offers an expansive toolbox for producing functional particles for a variety of applications,
including catalysis, microelectronics, photovoltaics, and cosmetics, in addition to
nanomedicine.[14] Bringing PRINT® technology and Spray-LbL functionalization together,
this work demonstrates a scalable, reproducible approach for fabrication of functional
carriers with exquisite control over particle composition, geometry, and surface properties,
providing an exciting platform for large-scale manufacture of highly-controlled multi-
functional nanocarriers.
Using the widely-reported top-down approach of PRINT® particle fabrication,
200×200×200nm PLGA nanoparticles (PLGA200×200nm) were fabricated and collected on a
low molecular weight polyvinyl alcohol (PVA) base coating atop a polyester support film.
While immobilized on the support film, the particles are arranged in a highly ordered 2-D
hexagonal array. The PVA supported particles were visualized by AFM and SEM. The
Morton et al. Page 3
Adv Mater. Author manuscript; available in PMC 2014 June 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
regular spatial arrangement of PRINT® particles coupled with the negative surface charge
of the acid-terminated PLGA NPs in water make them ideal candidates for rapid LbL
polyelectrolyte functionalization through spray-assisted LbL deposition (Spray-LbL). Initial
attempts to deposit aqueous solutions of polyelectrolytes onto the supported PRINT particles
resulted in a loss of the particles due to detachment from the substrate. This process could be
visualized by the loss of diffraction-based iridescence characteristic of the ordered
nanoparticle arrays (Figure 1B, 1C); this characteristic iridescence is indicative of highly
ordered particles on the harvesting layer, allowing for a convenient qualitative assessment of
particle immobilization or detachment. The loss of particles was confirmed with AFM and
SEM, which essentially show a complete absence of particles after the Spray-LbL process
due to the water solubility of the PVA backing. The reason for choosing PVA as the support
material for PRINT particles is in fact to enable facile particle harvesting (see Supplemental
Figure 1).
To avoid PVA dissolution, vapor-phase crosslinking using concentrated glutaraldehyde and
acid was employed to selectively crosslink the PVA adhesion layer to reduce its water
solubility, while avoiding any chemical changes to the relatively impermeable and inert
PLGA PRINT® nanoparticles. Contact angle measurements were carried out to study the
effects of the vapor-phase cross-linking reaction on the wettability of the PRINT® films. As
shown in the Figure 1A, pre-crosslinked NP arrays show considerable wettability, owing to
the presence of highly water-soluble and hydrophilic PVA polymer. After cross-linking, the
contact angle increased from 26° to 78° (Figure 1D), demonstrating that the films become
considerably more hydrophobic due to the formation of a glutaraldehyde cross-linked PVA
adhesive. Crosslinking conditions were also varied with results shown in Supplemental
Figure 2. As a result, the cross-linked films can be placed in water without particle
detachment. Following crosslinking, it was observed that particles could be readily
functionalized, as evidenced by maintenance of iridescence from the NP array following
each processing step (Figure 1E, 1F). This step therefore allowed for the deposition of
water-based polyelectrolytes using Spray-LbL.
As shown in Scheme 1, Spray-LbL on PRINT® nanoparticles, following vapor-phase cross-
linking of the PVA support films, is achieved by spraying an aqueous solution of cationic
polyelectrolyte is sprayed onto the NP containing films for 3 seconds and, after briefly
rinsing with water (3 seconds), an anionic polyelectrolyte is subsequently sprayed onto the
films (3 seconds). This cycle can then be repeated indefinitely to control the thickness of the
polyelectrolyte coating. In the final step, the particles are harvested by sonicating the films
in water, which causes the particles to detach from the PVA substrate.
Using AFM, the shape, persistence and uniformity of the particles were monitored with each
processing step, beginning with the initial NP array, followed by crosslinking, and
subsequent Spray-LbL deposition, as shown in Figure 2 (corresponding amplitude images
shown in Supplemental Figure 3). The versatility of this platform was further demonstrated
by coating a second PRINT® PLGA particle type, 80×80×320nm [PLGA80×320nm]. AFM
confirms that the particles are coated in a manner that maintains the uniformity of the
PRINT® particle template while building a film, observed by slight increase in height
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(~5nm/bilayer), which avoids bridging of neighboring particles and without causing
significant loss of particles during functionalization.
Particles were subsequently recovered via sonication, purified via filtration, and
concentrated using ultracentrifugation following Spray-LbL. A variety of techniques were
then used to illustrate the uniformity of the particles obtained from this fabrication method.
Dynamic light scattering analysis is shown in Table 1, with the corresponding histograms
shown in Supplemental Figure 4. For both particle types, uniformity of the particle
population is maintained as evidenced by the PDI of functionalized particles (see Table 1:
PRINT® PLGA200×200nm particles - original 0.01, 0.06 following deposition of three
bilayers of PLL/HA500K; PRINT® PLGA80×320nm particles – original 0.05). A slight
decrease in size following crosslinking is observed for both particle types, consistent with
the amount of material exposure to the crosslinking contraction forces on the PVA adhesive
layer. The change in size for functionalized particles is indicative of a very thin LbL film,
approximately 15-20nm for 3 bilayers of PLL/HA500K, based on dynamic light scattering
(Table 1) and confirmed with electron microscopy (Figures 3, 4). Histogram overlays also
illustrate the thin coatings applied to the particle surface (Supplemental Figure 4).
Characteristic surface charge reversal of the LbL deposition is also observed, as evidenced
by samples taken at different steps in the functionalization process. ζ-potential, measured at
25°C in 10mM NaCl, of pre- and post-XL NPs are approximately the same, while deposition
of materials post-XL results in surface charge characteristics consistent with the material
deposited (see Supplemental Figure 4). A range of polyelectrolyte multilayers were
explored, including poly-L-lysine (PLL)/hyaluronic acid (HA) [PLL/HA500K], PLL/dextran
sulfate (DXS) [PLL/DXS], PLL/poly(acrylic acid) [PLL/PAA], chitosan/HA [Chit/HA500K],
and chitosan/PAA [Chit/PAA] (see Supplemental Figure 4), further illustrating a primary
advantage of LbL as a means of tailoring the surface properties of these NP systems. These
films, while diverse in the range of materials incorporated, behaved similarly in coating the
NP systems without compromising the particle shape or significantly increasing the size
beyond a few tens of nanometers.
Recovered and purified particles visualized by electron microscopy, including SEM and
TEM, are displayed in Figures 3 and 4. Figures 3A and 3B are representative of the
uncoated, crosslinked PRINT® PLGA200×200nm particle array, along with the corresponding
recovered particles observed by both SEM (Figure 3C) and TEM (Figure 4B). The coated
array is shown in Figure 3D and 3E for direct comparison. A thin film coating is observed
on the particles in such a fashion that individual particle integrity is maintained prior to
recovery. Subsequent recovery yields the results in Figure 3F, where a thin coating of
approximately 20nm is observed to surround the entire particle surface by TEM (Figure 4B).
Observation of a conformal coating surrounding the entire nanoparticle is a surprising result
due to the inaccessibility of the spray deposition to the immobilized surface; however, it can
be explained by the unique feature of the electrostatic self-assembly LbL process to “self-
heal” defects in the adsorbed film.[15] The excess film that corrects for this defect in spray
LbL on PRINT® is observed in Figure 3E, whereby the film surrounding the individual
nanoparticle collapses in a manner that completely and smoothly seals the nanoparticle with
deposited film around the harvested particle following suspension. This phenomenon is also
observed for the PLGA80nm×320nm NPs. Displayed in Figure 3G and 3H are the uncoated,
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crosslinked PLGA80×320nm NP arrays, followed by the recovered particles visualized by
both SEM (Figure 3I) and TEM (Figure 4E). Compared to the coated NP arrays in Figure 3J
and 3K, the particles clearly grow in size in both dimensions following film deposition. This
thin film is also observed following recovery in using both SEM (Figure 3L) and TEM
(Figure 4E), where a coating of 20nm is observed around the entire particle. From these
data, it is clear that we can conformally coat PRINT® PLGA NPs with films around the
entire particle surface and in a manner that preserves the monodispersity of the platform.
After demonstrating the feasibility of spray functionalization and observing a conformal
coating surrounding two different PRINT® NP templates with a variety of coating materials,
it was important to examine the ability to control film growth using Spray-LbL. Control over
film thickness will allow precise tuning of drug release for therapeutic-containing NP
systems as well as functionalization of these material systems in such a way that does not
significantly impact the NP size or shape, which is a primary advantage of PRINT®
manufacture. From Figures 3, 4B, 4E, it was observed that three bilayers of PLL/HA (3
seconds/spray) generate a film of approximately 15nm. To observe whether thicker films
could be generated, high molecular weight polymers (Chitosan, 200K; HA, 500K) were
sprayed (3 seconds/spray) alternately to yield a 5 bilayer film. As expected, this film was
found to be significantly thicker, approximately 40nm by TEM (Figure 4C, 4F), while
conformally coating the NP surface so as to not compromise the NP shape. SEMs of the
coated backings and subsequent harvested and purified coated NPs for each PRINT®
template are displayed in Supplemental Figure 5. TEMs of each corresponding uncoated NP
systems are displayed in Figure 4A and 4D for reference. This effectively demonstrates the
capability of Spray-LbL as a means of tuning film thickness by incorporating higher
molecular weight polymers with more bilayer coatings. Additional parameters to tune film
thickness are longer spray times and higher concentrations of material sprayed.
As an additional test of particle functionalization, the polycationic layer, poly-L-lysine
(PLL), was labeled with a Cy5.5 dye (Lumiprobe, Cy5.5-NHS ester). Deposition was
tracked using fluorescence imaging and shown to significantly increase following layers 1
and 3, consistent with the subsequent addition of PLLCy5.5. This is also demonstrated by
directly comparing PLL/DXS films cast both with and without PLLCy5.5 using confocal
microscopy (Supplemental Figure 6).
While particle functionalization is clearly demonstrated and in a reproducible manner,
questions regarding biological functionality remained as this component of the carrier
system is critical to the translational relevance of the technology. Using the labeled
PLLCy5.5 Spray-LbL functionalized NP systems, particles were incubated with a triple
negative breast cancer cell line, BT-20. These cells, like many aggressive cancer cell types,
characteristically overexpress CD44 receptors[16], which are a convenient target for the
natural ligand, hyaluronic acid.[17] Previous work has also shown much promise for HA-
coated systems to provide a serum-stable, stealth-like platform for delivery.[2] Investigations
of cell-associated fluorescence in combination with confocal microscopy, shown in Figure
5A-5D, confirmed that these coatings are functional, as shown with enhanced levels of cell
uptake for the HA-coated systems. Further, increased uptake for HA-coated systems is clear
relative to the non-specific uptake of the DXS-terminated system, suggesting that film
Morton et al. Page 6
Adv Mater. Author manuscript; available in PMC 2014 June 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
construction can be finely tuned towards targeting specific cell populations. In this way,
Spray-LbL on PRINT® presents exciting opportunities to not only functionalize particles
scalably, reproducibly, and with extremely thin coatings but also in a manner that molecular
engagement of target cells can be achieved.
Particle shape also plays a significant role in cellular internalization, as shown in Figure
5E-5G. Coated PLGA80×320nm NPs ([PLL/HA]3) exhibited nearly 10-fold higher levels of
cell association relative to identically-coated PLGA200×200nm NPs within 2h of treatment, as
determined by FACS. This enhanced level of uptake is further complemented by confocal
microscopy, from which significantly more punctate NP fluorescence is observed inside the
cells for the PLGA80×320nm NPs. The impact of particle size and shape on cellular
internalization is of particular interest towards designing effective carrier systems that
further mediate endocytosis, in addition to surface chemical functionality. This proves
highly promising towards combination of optimal PRINT® technologies with target-specific
Spray-LbL architectures to maximize therapeutic impact of these NP systems.
Spray-LbL on PRINT® is a significant advance in the design of nanotechnology, as it
provides an exciting platform for large-scale production of built-to-order functional
nanoparticle systems, whereby we have precise control of the physicochemical
characteristics of the NP systems developed. This includes the ability to finely tune the NP
shape, size, chemical composition, and surface characteristics towards manufacture of
systems that maximize cellular entry and optimize drug and NP pharmacokinetics in vivo.
Further, the ability to rapidly and scalably manufacture these systems is realizable, as
PRINT® technology is capable of roll-to-roll NP fabrication while spray can be applied in a
continuous fashion. This compatibility in continuous manufacture and subsequent
functionalization of NP systems presents a highly attractive opportunity for highly
reproducible manufacture of customizable NP systems for a wide variety of applications.
Experimental
All materials and equipment necessary for PRINT® particle fabrication were maintained in
a clean room under controlled conditions at UNC-Chapel Hill. Bulk material, including rolls
of poly(ethylene terephthalate) [PET], poly(vinyl alcohol) [PVA]-coated PET, and pre-made
molds cast from a perfluoropolyether (PFPE) material, were provided by Liquidia
Technologies. All chemicals used were provided by Sigma Aldrich, except for hyaluronic
acid, provided by Lifecore Biomedical, and Cy5.5-NHS from Lumiprobe.
PRINT® Nanoparticle Fabrication
PRINT® particle fabrication follows a well-established protocol.[9] Briefly, the polymeric
material, poly(lactide co-glycolic acid) [PLGA], used for particle molding was dissolved in
dichloromethane. A film of PLGA was cast using a mayer rod (#3) on a high energy PET
backing prior to lamination of this film to the pre-cast mold at 320°F. The filled mold from
this step was laminated at 320°F to a transfer adhesive film (PVA) cast on a PET backing.
The particles were preserved in this state via vacuum seal under N2 atmosphere until ready
for functionalization.
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Vapor-phase Glutaraldehyde Crosslinking
Molded nanoparticles were delaminated from the mold onto the transfer adhesive film.
Sections of these harvested particles were subjected to PVA-crosslinking conditions in an
enclosed chamber via vapor-phase glutaraldehyde crosslinking to further immobilize the
particles for spray-LbL deposition. This was done via incubation of the particle arrays with
vials containing 50% glutaraldehyde (in water) and 10% aqueous acid (HCl) for 15h. Arrays
following crosslinking were removed for subsequent functionalization.
Spray Layer-by-Layer Deposition
Materials were deposited onto the surface of crosslinked nanoparticle arrays by
aerosolization of polyelectrolytes for spray times of ~3 seconds, with ~3 second wash steps
between each layer. Polyelectrolytes were sprayed at a concentration of 1mg/mL. A final
water rinse was used prior to drying and subsequent analysis and/or recovery of
functionalized particles. Particles recovered following spray-LbL were harvested by
sonication of the functionalized particle arrays in water for ~15minutes. The collected
particles were subsequently purified via centrifugation and filtration through a 0.45μm
syringe filter.
Nanoparticle Characterization
Images to assess iridescence of the nanoparticle arrays following each processing step were
obtained by photography with a 5-megapixel camera (iPhone 4). Contact angle
measurements and images (Rame-Hart model 500 goniometer with Nikon camera) were
obtained immediately following drop-casting a bubble of water on the NP array. Dynamic
light scattering (Malvern ZS90) was used to determine the hydrodynamic diameter of the
nanoparticles. Zeta potential measurements were also performed using the Malvern ZS90.
Measurements were conducted in 10mM NaCl in millipore water at 25°C.
Scanning electron micrographs were collected using a JEOL 6700 high resolution
microscope. Sample preparation included drop-casting on a silicon wafer followed by
sputter coating with gold-palladium (~3nm). Transmission electron micrographs were
collected using a JEOL 2010 Advanced High Performance TEM. Sample preparation
included drop-casting on a carbon/formvar-coated copper grid. Atomic force microscopy
data was collected using a MultiMode™ atomic force microscope with a NSC15/AIBS,
325kHz, 46N/m tip from μmasch in tapping mode.
Confocal microscopy (Nikon A1R scanning confocal microscope) was conducted following
incubation of the functionalized nanoparticles (tracked via labeled PLL, PLLCy5.5) at 37°C
with BT-20 cells. Fixed samples included a DAPI and Phalloidin-488 stain, in addition to
particle tracking Cy5.5 label. Flow cytometry (BD LSRFortessa) was performed in parallel
with confocal microscopy to quantitatively assess particle association (tracking via
PLLCy5.5) with cells following incubation at 37°C. Particles administered were normalized
against the fluorescent intensity (λex=675nm, λem = 710nm), as measured by a Tecan
Microplate Reader, of the labeled polycationic layer deposited initially on the NP surface.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Contact angle and particle iridescence characterization pre- and post-functionalization
(a) Contact angle measurement and image of pre-crosslinked NP array. (b) Particle
iridescence observed in the ordered particle array post-PRINT® fabrication. (c) Loss of
iridescence following spray of water-based polyelectrolytes, indicative of complete loss of
particles. (d) Contact angle measurement and image of post-crosslinked NP array
(glutaraldehyde/HCl vapor phase crosslinking). Particle iridescence is maintained following
(d) 15h crosslinking and (f) Spray-LbL deposition of [PLL/HA]3.
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Figure 2. AFM characterization of nanoparticle arrays - height
(a) Pre-crosslinked PLGA200×200nm NP array; (b) PLGA200×200nm NP array following
crosslinking; (c) PLGA200×200nm/(PLL/HA500K)3. (d) Pre-crosslinked PLGA80×320nm NP
array; (e) PLGA80×320nm NP array following crosslinking; (f) PLGA80×320nm/(PLL/
HA500K)3. Scale bars representative of 2μm. Color scale representative of linear gradient
from 0 [bottom] to 200 nm [top].
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Figure 3. SEM characterization of particles pre- and post-Spray-LbL functionalization
SEM of (a,b) uncoated, crosslinked 200×200nm PLGA NP array; (c) purified uncoated,
crosslinked 200×200nm PLGA NPs; (d,e) coated 200×200nm PLGA NP array [(PLL/
HA)3]; (f) purified coated 200×200nm PLGA NPs [(PLL/HA)3; (g,h) uncoated, crosslinked
80×320nm PLGA NP array; (i) purified uncoated, crosslinked 80×320nm PLGA NPs; (j,k)
coated 80×320nm PLGA NP array [(PLL/HA)3]; (l) purified coated 80×320nm PLGA NPs
[(PLL/HA)3]. Scale bars representative of 200nm.
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Figure 4. TEM characterization of particles pre- and post-Spray-LbL functionalization -
controlling film thickness
TEM of (a) uncoated, crosslinked 200×200nm PLGA NPs; (b) purified coated 200×200nm
PLGA NPs [(PLL/HA)3]; (c) purified coated 200×200nm PLGA NPs [(Chit/HA)5]; (d)
uncoated, crosslinked 80×320nm PLGA NPs; (e) purified coated 80×320nm PLGA NPs
[(PLL/HA)3]; (f) purified coated 80×320nm PLGA NPs [(Chit/HA)5]. Scale bars
representative of 100nm. TEMs of uncoated, uncrosslinked NPs are displayed in
Supplemental Figure 10.
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Figure 5. Confocal microscopy and cell-associated fluorescence of Spray-LbL PRINT® particles
via tracking with PLLCy5.5 polycationic component – investigation of variable coatings, coating
thickness, and NP shape
Confocal microscopy of (a) PLGA200×200nm/PLL/HA500K NPs [L2 HA], (b)
PLGA200×200nm/(PLL/HA500K)3 NPs [L6 HA], (c) PLGA200×200nm/PLL/DXS NPs [L6
DXS] incubated with BT-20 cells for 6h at 37°C. NPs labeled with PLLCy5.5 as first
polycationic component in film and normalized in dose based on the absorbance of this layer
on the functionalized NPs. (d) Mean cell-associated fluorescence [Cy5.5 channel (λex =
640nm, λem = 700nm)] for each NP formulation displayed in (a)-(c). Data presented as the
average +/− SEM of triplicate measurements. Confocal microscopy of (e) PLGA80×320nm/
(PLL/HA500K)3 NPs and (f) PLGA200×200nm/(PLL/HA500K)3 NPs incubated with BT-20
cells for 2h at 37°C. NPs labeled with PLLCy5.5 as first polycationic component in film and
normalized in dose based on the absorbance of this layer on the functionalized NPs. (g)
Mean cell-associated fluorescence [Cy5.5 channel (λex = 640nm, λem = 700nm)] for each
NP formulation displayed in (e)-(f). Data presented as average +/− SEM of triplicate
measurements. Confocal microscopy images representative of overlays of individual
fluorescence channels displayed below [from left to right under each overlay: DAPI nuclear
stain, phalloidin-488 stain, NP fluorescence – Cy5.5].
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Scheme 1. Spray-LbL on PRINT® nanoparticles
PRINT® particles were fabricated and used while immobilized in a post-harvesting array for
Spray-LbL. Arrays were subsequently crosslinked under vapor-phase glutaraldehyde/
concentrated acid conditions, followed by LbL application (sequential deposition of
polycation/wash/polyanion/wash comprising one bilayer). Functionalized particles were
harvested by sonication of the arrays in water and purified by filtration and
ultracentrifugation.
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Table 1
Nanoparticle physicochemical characterization
Dynamic light scattering data, based on z-average hydrodynamic diameter, and zeta-potential measurements
were conducted at 25°C in 10mM NaCl/deionized water. Data is presented for purified, uncoated
PLGA200×200nm and PLGA80×320nm NPs, purified PLGA200×200nm and PLGA80×320nm following crosslinking,
and coated NPs: PLGA200×200nm/(PLL/HA500K)3 and PLGA80×320nm/(PLL/HA500K)3. Data for mean
hydrodynamic diameter and zeta-potential are presented as average +/− standard error of the mean for
triplicate measurements.
Spray-LbL
on PRINT® PLGA200×200nm
PLGA200×200nm
XL
PLGA200×200nm/
(PLL/HA)3 PLGA80×320nm
PLGA80×320nm
XL
PLGA80×320nm/
(PLL/HA)3
Mean dh [nm]
+/− SEM 237 +/− 2 229 +/− 3 244 +/− 2 221 +/− 1 192 +/− 2 214 +/− 5
PDI 0.01 0.03 0.06 0.06 0.1 0.05
ζ potential
[mV] +/− SEM −6 +/− 0.1 −8 +/− 2 −28 +/− 1 −10 +/− 2 −13 +/− 0.5 −24 +/− 2
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